Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene

International Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 554-560

  Deguen, Brigitte ^a   Goutebroze, Laurence ^a   Giovannini, Marco ^a   Boisson, Cécile ^a   Van der Neut, Ronald ^a   Jaurand, Marie Claude ^b   Thomas, Gilles ^a,c,d  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN;

ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MENINGIOMA; MESOTHELIOMA; MUTATION; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ALLELES; ELECTROPHORESIS; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; LOSS OF HETEROZYGOSITY; MEMBRANE PROTEINS; MESOTHELIOMA; NEOPLASM PROTEINS; NEUROFIBROMIN 2; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED;

EID: 0031874488     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6     Document Type: Article

References (31)

1. BIANCHI, A.B., MITSUNAGA, S.-I., CHENG, J.Q., KLEIN, W.M., JHANWAR, S.C., SEIZINGER, B., KLEY, N., KLEIN-SZANTO, A.J.P. and TESTA, J.R., High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc. nat. Acad. Sci. (Wash.), 92, 10854-10858 (1995).
2. BJÖRKQVIST, A.M., TAMMILEHTO, L., NORDLING, S., NURMINEN, M., ANTTILA, S., MATTSON, K. and KNUUTILA, S., Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Brit. J. Cancer, 77, 260-269 (1998).
3. CARBONE, M. and 12 OTHERS, Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nature (Med.), 3, 908-912 (1997).
4. CHENG, J.Q., JHANWAR, S.C., KLEIN, W.M., BELL, D.W., LEE, W.-C., ALTOMARE, D.A., NOBORI, T., OLOPADE, O.I., BUCKLER, A.J. and TESTA, J.R., p16 alterations and deletion mapping of 9p21-22 in malignant mesothelioma. Cancer Res., 54, 5547-5551 (1994).
5. COLLINS, J.E. and 31 OTHERS, A high-density YAC contig map of human chromosome 22. Nature (Lond.), 377, 367-379 (1995).
6. COTE, R.J., JHANWAR, S.C., NOVICK, S. and PELLICER, A., Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cancer Res., 51, 5410-5416 (1991).
7. DEGUEN, B., MÉREL, P., GOUTEBROZE, L., GIOVANNINI, M., REGGIO, H., ARPIN, M. and THOMAS, G., Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane. Hum. mol. Genet., 7, 217-226 (1998).
8. DE LUCA, A., BALDI, A., ESPOSITO, V., HOWARD, C.M., BAGELLA, L., RIZZO, P., CAPUTI, M., PASS, H.I., GIORDANO, G.G., BALDI, F., CARBONE, M. and GIORDANO, A., The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nature (Med.), 3, 913-916 (1997).
9. DEN BAKKER, M.A., TASCILAR, M., RIEGMAN, P.H.J., HEKMAN, A.C.P., BOERSMA, W., JANSSEN, P.J.A., DE JONG. T.A.W., HENDRIKS, W., VAN DER KWAST, T.H. and ZWARTHOFF, E.G., Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Amer. J. Pathol., 147, 1339-1349 (1995).
10. DIB, C. and 13 OTHERS, A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380, 152-154 (1996).
11. DURIEZ, C. and 16 OTHERS, Localisation d'un gène suppresseur de tumeur distal à D22S270 dans les cancers colorectaux. Gastroenterol. clin. Biol., 21, 358-364 (1997).
12. EVANS, D.G.R., HUSON, S.M., DONNAI, D., NEARY, W., BLAIR, V., NEWTON, V. and HARRIS, R., A clinical study of type 2 neurofibromatosis. Quart. J. Med., 84, 603-618 (1992).
13. FLEURY-FEITH, J., KHEUANG, L., ZENG, L., BIGNON, J., BOUTIN, C., MONNET, I. and JAURAND, M.-C., Human malignant mesothelial cells: variability of ultrastructural features in established and nude mice transplanted cell lines. J. Pathol., 177, 209-215 (1995).
14. HAGEMEUER, A., VERSNEL, M.A., VAN DRUNEN, E., MORET, M., BOUTS, M.J., VAN DER KWAST, T.H. and HOOGSTEDEN, H.C., Cytogenetic analysis of malignant mesothelioma. Cancer Genet. Cytogenet., 47, 1-28 (1990).
15. HERMAN, J.G., LATIF, F., WENG, Y., LERMAN, M.I., ZBAR, B., LIU, S., SAMID, D., DUAN, D.-S.R., GNARRA, J.R., LINEHAN, W.M. and BAYLIN, S.B., Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. nat. Acad. Sci. (Wash.), 91, 9700-9704 (1994).
16. JACKS, T., Tumor suppressor gene mutations in mice. Ann. Rev. Genet., 30, 603-636 (1996).
17. KLEYMENOVA, E.V., BIANCHI, A.A., KLEY, N., PYLEV, L.N. and WALKER, C.L., Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma. Mol. Carcinogenesis, 18, 54-60 (1997).
18. LUTCHMAN, M. and ROULEAU, G.A., The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res., 55, 2270-2274 (1995).
19. MCINTOSH, I., HAMOSH, A. and DIETZ, H.C., Nonsense mutations and diminished mRNA levels. Nature(Genet.), 4, 219 (1993).
20. MÉREL, P. and 17 OTHERS, Screening for germ-line mutations in the NF2 gene. Genes Chromosomes Cancer, 12, 117-127 (1995a).
21. MÉREL, P. and 15 OTHERS, Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer, 13, 211-216 (1995b).
22. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature (Med.), 1, 686-692 (1995).
23. ROULEAU, G.A. and 20 OTHERS, Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature (Lond.), 363, 515-521 (1993).
24. RUFFIE, P.A., Pleural mesothelioma. Curr. Opin. Oncol., 3, 328-334 (1991).
25. SATO, N., FUNAYAMA, N., NAGAFUCHI, A., YONEMURA, S., TSUKITA, SA. and TSUKITA, SH., A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J. Cell Sci., 103, 131-143 (1992).
26. SEKIDO, Y., PASS, H.I., BADER, S., MEW, D.J.Y., CHRISTMAN, M.F., GAZDAR, A.F. and MINNA, J.D., Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res., 55, 1227-1231 (1995).
27. STEMMER-RACHAMIMOV, A.O., XU, L., GONZALEZ-AGOSTI, C., BURWICK, J.A., PINNEY, D., BEAUCHAMP, R., JACOBY, L.B., GUSELLA, J.F., RAMESH, V. and LOUIS, D.N., Universal absence of merlin, but not other ERM family members, in schwannomas. Amer. J. Pathol., 151, 1649-1654 (1997).
28. TAGUCHI, T., JHANWAR, S.C., SIEGFRIED, J.M., KELLER, S.M. and TESTA, J.R., Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res., 53, 4349-4355 (1993).
29. TIKOO, A., VARGA, M., RAMESH, V., GUSELLA, J. and MARUTA, H., An anti-ras function of neurofibromatosis type 2 gene product (NF2/merlin). J. biol. Chem., 269, 23387-23390 (1994).
30. TROFATTER, J.A. and 20 OTHERS, A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell, 72, 791-800 (1993).
31. ZENG, L., FLEURY-FEITH, J., MONNET, I., BOUTIN, C., BIGNON, J. and JAURAND, M.-C., Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum. Pathol., 25, 227-234 (1994).